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Abstract
Background: Ahmedabad is an industrial city in Gujarat, India. In 2003, the HIV prevalence among
commercial sex workers (CSWs) in Ahmedabad reached 13.0%. In response, the Jyoti Sangh HIV
prevention programme for CSWs was initiated, which involves outreach, peer education, condom
distribution, and free STD clinics. Two surveys were performed among CSWs in 1999 and 2003. This
study estimates the cost-effectiveness of the Jyoti Sangh HIV prevention programme.
Methods: A dynamic mathematical model was used with survey and intervention-specific data from
Ahmedabad to estimate the HIV impact of the Jyoti Sangh project for the 51 months between the two
CSW surveys. Uncertainty analysis was used to obtain different model fits to the HIV/STI epidemiological
data, producing a range for the HIV impact of the project. Financial and economic costs of the intervention
were estimated from the provider's perspective for the same time period. The cost per HIV-infection
averted was estimated.
Results: Over 51 months, projections suggest that the intervention averted 624 and 5,131 HIV cases
among the CSWs and their clients, respectively. This equates to a 54% and 51% decrease in the HIV
infections that would have occurred among the CSWs and clients without the intervention. In the absence
of intervention, the model predicts that the HIV prevalence amongst the CSWs in 2003 would have been
26%, almost twice that with the intervention. Cost per HIV infection averted, excluding and including peer
educator economic costs, was USD 59 and USD 98 respectively.
Conclusion: This study demonstrated that targeted CSW interventions in India can be cost-effective, and
highlights the importance of replicating this effort in other similar settings.
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The HIV epidemic in India is no longer negligible, with an
estimated 5.7 million people living with HIV in 2005
(0.91% of the adult population) [1]. Although the overall
prevalence in India may be below 1%, in the southern
states of Andhra Pradesh, Karnataka and Maharashtra,
and the north-eastern states of Manipur and Nagaland,
the ante-natal clinic prevalence is above 1% [2]. In Gujarat
the prevalence is generally much lower (0.13% among
ante-natal clinic attendees in 2004). However, in the city
of Ahmedabad, the HIV prevalence in 2003 amongst ante-
natal clinic attendees was 0.75%, and was 13.2% amongst
CSWs [3,4]. This is particularly concerning since Ahmeda-
bad is the seventh largest city in India with a population
of over 4.5 million in 2005 [5].
Under guidance and support from the Ahmedabad
Municipal Corporation AIDS Control Society (AMCACS),
HIV prevention programmes in Ahmedabad started in
1997. Currently there are 26 operational HIV prevention
projects among different sections of the society. One of
these is the CSW prevention project run by Jyoti Sangh, a
non-governmental organisation that promotes the wel-
fare and empowerment of women [4]. This project is sup-
ported by the Department for International Development,
UK, and is an integral part of the National AIDS Control
Programme implemented across India under the guidance
of NACO [4].
Jyoti Sangh has contact with CSWs from different areas of
the city that work on the street and in other settings such
as brothels and beauty parlours. Their four main strategies
for reducing HIV transmission include: (1) Increase the
knowledge of HIV/AIDS and sexually transmitted infec-
tions (STI) among CSW; (2) Improve the STI treatment of
CSW and their clients; (3) Increase safer sex practices
among CSW; and (4) Provide an environment that ena-
bles CSWs and the sex industry to promote safe sex behav-
iours. Outreach workers, assisted by peer educators, visit
CSWs regularly to distribute condoms, promote safer sex
practices and encourage CSWs to attend the free STI clinic.
Using snowballing methods, Jyoti Sangh estimated that
there are 4,000 (range 3,500–4,500) CSWs in Ahmeda-
bad, and that since 1998, the number of CSWs reached by
them has increased from 400 to over 3,050 in 2004.
In order to evaluate the impact of the Jyoti Sangh HIV pre-
vention programme on sexual risk behaviour and preva-
lence of HIV and other STIs, two surveys were undertaken
in August/September 1999 and November/December
2003. The surveys assessed the laboratory prevalence of
Chlamydia trachomtis, Neisseria gonorrhoea, syphilis and
Trichomonas vaginalis, and HIV, along with their behav-
ioural correlates, such as condom usage and the number
of clients per day. Over the 51 months between these sur-
veys, Jyoti Sangh distributed over 5.5 million condoms. In
addition, from January 2001 to December 2003, on aver-
age 2,342 CSWs were reached per month and 58 people
were treated for STDs by the free clinic (range: 5 to 221 per
month). Compared to the 1999 survey, the 2003 survey
demonstrated a significant decrease in the prevalence of
treatable STIs and a stabilisation of the HIV prevalence;
this was reflected in a significant decrease in the reported
number of sexual partners and a significant increase in
consistent condom use [6].
This study aims to evaluate the Jyoti Sangh HIV interven-
tion programme by using mathematical modelling and
cost-effectiveness analysis with setting-specific epidemio-
logical, behavioural and intervention data. The impact of
the intervention is estimated in terms of HIV cases averted
amongst CSW and their clients, and its cost-effectiveness
as Indian rupees (INR) and US dollars (USD) per HIV case
averted.
Methods
Snow-balling (a gradual process through peer educators
and outreach workers) was used to estimate the total
number of CSWs in Ahmedabad for the two cross-sec-
tional epidemiological and behavioural surveys under-
taken among CSWs in August/September 1999 and
November/December 2003. In the 1999 survey, a conven-
ient sample of 314 CSWs was recruited from the 400–500
CSWs with whom Jyoti Sangh had rapport through out-
reach workers and peer educators. In the 2003 survey, 385
CSWs were sampled from a sampling frame of 1011 out
of 3000 who expressed their willingness to participate in
the study. The sample size was decided using a power cal-
culation of 95% confidence intervals (CI) and 80% power
based on the assumption that there would be at least 15%
decrease in the prevalence of STIs among CSWs since the
previous survey. A two-stage stratified cluster sampling
was employed in which CSWs were stratified according to
their work setting and sampling was carried out according
to strata which represent the real proportion of different
types of CSW in the population (Table A1) [4]. Data from
these surveys were used to parameterise and fit a mathe-
matical model to estimate the impact of the intervention
over the 51 months between the mid-points of the two
survey periods – the beginning of September 1999 to the
end of November 2003. Mean ages of both surveys were
similar (31.2 years in 1999 compared to 33 years in
2003), although the state of origin was slightly different
and the proportions living with a husband or alone were
slightly lower in 1999. A comparison of the designs (Table
A1) and background characteristics of CSWs (Table A2) of
the two surveys can be found in Appendix 1 [See Addi-
tional file 1] [4]. Cost data was also collected over this
period so that the cost-effectiveness of the intervention
could be estimated.Page 2 of 13
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A deterministic mathematical model, Sex Work Gujarat
1.2 (Peter Vickerman and Charlotte Watts, LSHTM, UK)
was used to assess the impact of the Jyoti Sangh interven-
tion on HIV and STI transmission amongst CSWs in
Ahmedabad. For this epidemiological setting, the model
was used to estimate how changes in sexual behaviour
and condom use and improvements in STI treatment,
associated with being in contact with the intervention,
may have reduced HIV and STI transmission.
Using behavioural and epidemiological data, the model
divides the CSWs into sub-groups according to their level
of condom use ('None of the time', 'Some of the time' and
'All of the time') and STI and HIV infection status. Estab-
lished mathematical techniques [7] are used to estimate
how HIV and a generic STI spread within the different
CSW sub-groups and their clients over time with or with-
out the intervention programme. By comparing these two
scenarios, the relative decrease in HIV incidence and prev-
alence and the number of HIV infections averted by the
intervention amongst CSWs and their clients can be esti-
mated. The facilitation of HIV transmission by the pres-
ence of STIs in a sexual relationship [8,9] and the initial
high viraemia stage of HIV [10] are incorporated into the
model. The model equations are included in Appendix 2
[See Additional file 2].
Data for mathematical model
The model was parameterised with behavioural data from
the two surveys undertaken amongst CSWs by Jyoti
Sangh, intervention-specific output data and data from
the scientific literature. There were no data collected from
clients, and so behavioural data for the clients were
obtained from national surveys of paying clients of CSWs
undertaken in 2001 by NACO [11]. There were no HIV or
STI epidemiological data for the clients as they were noto-
riously difficult to collect data from. Because of this, the
model's projections of the clients' STI and HIV prevalence
amongst clients were not included as part of the fitting
regime, and so were not restricted by any observed data.
The different data used to parameterise the model are
described below and are shown in Table 1.
Epidemiological data
Data on HIV and STI prevalence were reported in the two
surveys. The HIV prevalence amongst surveyed CSWs was
11.7% (95% CI: 8.4–15.9%) in 1999 and 13.2% (95% CI:
10.1–16.9%) in 2003. The prevalence of different STIs is
shown in Table 2, including details of the tests used. There
has been a significant reduction in the overall prevalence
of treatable STIs amongst CSWs, with 75.5% (95% CI:
70.3–80.1%) of CSWs having at least one STI in 1999
whereas in 2003, this had reduced to 51.6% (95% CI:
46.57%–56.78%). Because the model only simulates the
transmission of one generic STI it was decided that it
would be fit to the overall prevalence of STIs amongst
CSWs in 1999 and 2003. Although this simplifies the
nature of STI transmission, it was done to mimic the over-
all effect of treatable STIs on HIV transmission before and
after the intervention. The model did not simulate the
transmission of Herpes Simplex Virus-2 (HSV-2) because
of a lack of epidemiological data. However, it was hoped
that the effect of HSV-2 on HIV transmission was incorpo-
rated in a crude way within the HIV transmission proba-
bility at baseline through the uncertainty that was
attached to this model parameter. It was assumed that this
effect remained constant over the duration of the evalua-
tion.
Behavioural data
Data regarding condom use and other sexual behaviour
were obtained through self-reporting from the two inter-
vention surveys. In addition, data from the Jyoti Sangh
monthly monitoring reports were also used to estimate
the number of clients per CSW per month.
The monitoring reports gave monthly estimates for the
average number of sexual intercourses each CSW had per
day for May 2002 to December 2003. By assuming one
coital act per client, this data suggested that each CSW had
on average 119 (range: 107 and 140) clients per month
over this period. This was used for the CSWs reached by
the intervention.
Because monitoring reports were not collected before
2002, and because only categorical data was collected in
the behavioural surveys (proportion of CSWs that had less
than 2, between 2 and 5 and over 5 clients per day), the
client frequency for CSWs not reached by the intervention
had to be estimated in other ways. This was done by using
the monitoring data from 2002–2003 to calibrate the dis-
tribution data from the 2003 intervention survey, so
replacing the categorical ranges of clients per day with
point estimates. These point estimates were then used to
calibrate the distributional data from the 1999 survey,
and so produce estimates for the average client frequency
per CSW not reached by the intervention – 133 (range:
119–157) clients per month. For details, see Appendix 3
[see Additional file 3].
Coverage of STD services
The number of CSWs reached and STI cases treated by the
clinic per month were obtained from the monthly reports
of Jyoti Sangh for January 2001 to December 2003.
Monthly reports for earlier years are no longer available.
The proportion of CSWs reached using STD services per
month was calculated by dividing the monthly estimates
of STIs treated with the estimated number of CSWs
reached by the intervention in that month that had at leastPage 3 of 13
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Definition of model inputs Model inputs (boundaries or in 
italics: 95% CI)
Probability Distribution Date of behavioural survey and reference for 
model input values
Coverage and Impact
Overall number of sex workers in 
Ahmedabad
4000 (3500–4500) Triangular Estimated by staff and peer educators of Jyoti 
Sangh through snow-balling method. Also 
personal communication with GJ on 7 July 
2005.
Proportion of CSW recently reached 
by Jyoti Sangh intervention
0.586 (0.521–0.669) Triangular Average number of CSWs covered by the 
intervention program.
Number covered/Total number = 2342/4000 
= 0.5855
Max.: Number covered/min. total number = 
2342/4500 = 0.5205
Min: Number covered/max. total number = 
2342/3500 = 0.6692
(According to the routine data collected in 
monthly reports between Jan 2001 and Dec 
2003)
Proportion of CSW reached using 
STD services per month
0.028 (0.028–0.041) Uniform Average of percentage of STD treatments 
(Female) in those CSWs covered by the 
programme who are believed to have STIs 
(Low estimate: 51.6%; High estimate: 75.5%; 
figures from [6] calculated from the 
percentage of CSW who do not have any 
STIs)
Average proportion of STDs treated 
effectively cured
0.8 (0.7–0.9) Triangular No data, treatment is assumed to be fairly 
effective.
Proportion reporting using condoms: Intervention survey data from 1999 and 2003 
[4]. 95% CI confidence intervals calculated 
using STATA.
Before/Unreached:
Never 0.38 (0.33–0.44) Normal
Sometimes 0.29
(0.24–0.34)
Normal
Always 0.33
(0.27–0.37)
Normal
After/Reached:
Never 0.047 (0.028–0.073) Normal
Sometimes 0.14 (0.11–0.18) Normal
Always 0.80 (0.75–0.84) Normal
Epidemiological
Initial HIV prevalence amongst sex 
workers (first survey from 1999)
11.7% (8.4%–15.9%) Normal Survey data from 1999 [4] (Lower and upper 
estimates are 95% confidence intervals of the 
point estimates).
Average duration of generic STD 
included in model (months)
Varied in order to fit the STD prevalence in 
1999 and 2003 surveys [6].
CSW 1 (0.5–1.5) Uniform
CL 1 (0.5–1.5) Uniform
Average duration of initial high 
infectivity phase (months)
1.5 (1–2) Triangular [10]
Average median duration between 
HIV infection and morbidity (months)
95 Constant Median disease progression from HIV infection 
to AIDS takes 7.9 years in a cohort study in 
Mumbai, India. This was drawn from a 
truncated Weibull distribution [36].
Behavioural
Average time span women sell sex 
(months)
(90–180) Uniform In the 2003 survey, average age of CSW = 33 
years, average age when became CSW = 25.4 
years [6]. Difference was used to estimate the 
lower bound, and the upper bound was set to 
twice the lower bound.
Average time span men buy sex 
(months)
(60–120) Uniform Median age (range) of CL is 28 (18,49); Median 
age at first sex with any commercial female 
partner (range) is 23 (10,40) [37]. Difference 
was used to estimate the lower bound, and 
the upper bound was set to twice the lower 
bound
Average number of clients per month 
per unreached CSW (using 1999 
figure)
133 (119–157) N/A Average number of sexual partners per day 
during last month [6] and data from routine 
monthly reports between May 2002 and 
December 2003 were used to calculate an 
average.Page 4 of 13
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per reached sex worker (using 2003 
figure)
119 (107–140) Triangular Monthly reports of Jyoti Sangh from May 2002 
to Dec 2003.
Average additional number of clients 
per month per unreached CSW
14 (11.6–17.0) Uniform Difference between the two figures above, 
calculated using Solver, using percentages from 
the two surveys [6].
Number of sex acts between one 
client and one sex worker in one 
encounter
1 -- No data. It is assumed to be near one, and that 
after discussion with GJ it was decided to be 
one.
Average number of CSWs seen by 
clients per month
(1–8) Uniform NACO survey reported median number of 
commercial female partners seen by a client in 
the last 3 months is 6 (1,27) [37]. However, 
high estimates of this parameter result in very 
high STI prevalences and so a lower range was 
used for modeling.
Proportion of time condom used, 
corresponding to:
"None of the time" 0 (0–0.2) Triangular Zero was chosen as point estimate as it is the 
conservative estimation based on the 
definition "None of the time".
"Some of the time" 0.5 (0.2–0.7) Triangular Question framed in the questionnaire is 2 or 3 
out of 5. So mean of 40% and 60% is 50% [6].
"All of the time" 0.8 (0.7–1) Triangular Question framed in the questionnaire is > 3 
out of 5. So mean of 60% and 100% is 80% [6].
Transmission Probabilities
Transmission probability of HIV per 
sex act:
[12, 14, 38]
Male to Female 0.002 (0.001–0.003) Uniform
Female to Male 0.001 (0.0005–0.003) N/A
Ratio of transmission probability: 
(Female to Male)/(Male to Female)
0.5 (0.5–1) Triangular
Transmission probability of generic 
STD per sex act:
[13, 15-20]
Male to Female 0.25 (0.1–0.5) Triangular
Female to Male 0.25 (0.1–0.5) Triangular
STD cofactor effect per sex act 3.1 (1.2–5) Triangular [8, 9]
Multiplicative cofactor during high 
viraemia phase of HIV infection
15 (10–20) Triangular [21, 22]
Proportion of time condom used that 
provides protection
0.85 (0.8–0.9) Triangular [23, 24]
CSW: commercial sex workers. GJ: Prof. Gaurang Jani. STI: sexually transmitted infection. STD: sexually transmitted disease. Note: If a certain value was 
calculated from a population sample, then a normal distribution was used and the range is the 95% confidence interval. If it was not produced from a population 
sample, then the range is the proposed uncertainty in the parameter used for the model uncertainty analysis, and if it was thought that one value was more likely 
then a triangle distribution was used. If no information existed on which value was more likely, then a non-informative uniform distribution was used.
Table 1: Model Input parameters and distribution types used in uncertainty analysis (Continued)Page 5 of 13
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Table 2: Prevalence of different sexually transmitted infections and HIV among CSWs in two cross-sectional surveys in 1999 and 2003 
[6]
STI 1999 N = 314 Prevalence (%) (95%CI) 2003 N = 385 Prevalence (%) (95%CI)
Trichomonas† 128 40.8 (35.3–46.4) 106 27.5 (23.1–32.3)
Gonorrhoea‡ 60 19.1 (14.9–23.9) 23 6.0 (3.8–8.8)
Chlamydia* 53 16.9 (12.9–21.5) 37 9.6 (6.9–13.0)
Syphilis RPR 76 24.2 (19.6–29.3) 67 17.4 (13.5–21.6)
Syphilis TPHA 130 41.4 (35.0–47.1) 155 40.3 (35.3–45.4)
N = 314 N = 401
HIV** 37 11.7 (8.4–15.9) 53 13.2 (10.1–16.9)
CSWs: commercial sex workers † Wet Mount Microscopy and culture were used on vaginal swab sample ‡ Gram stain, culture in modified Thayer 
Martin (MTM)/modified New York culture (MNYC) media and antibiotic susceptibility test (and in 1999, PAGE2 as well) were used on endocervical 
swab sample. * PACE-2 test (and in 1999, Enzyme Immunoassay as well) were used on endocervical sample ** Double Enzyme-Linked ImmunoSorbent 
Assay (ELISA) test was used on serum sample. RPR: Rapid plasma regain. TPHA: Treponema Pallidum Haemagglutination test.
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number of CSWs reached each month (from the monthly
reports) by the overall prevalence of curable STIs from the
1999 (75.5%) or 2003 (51.6%) survey. These high and
low estimates for each month were then averaged to give
bounds for the proportion of CSWs reached using STD
services per month.
Inputs from literature
The transmission probabilities for HIV [12-14] and the
generic STD included in the model [13,15-20], STD cofac-
tor effects per sex act [8,9], multiplicative factor during
high infectivity phase [21,22] and proportion of time con-
dom used that provides protection [23,24] were obtained
from the literature.
Model uncertainty analysis
Since there was uncertainty in the data used to parameter-
ise the model (Table 1), an uncertainty analysis was con-
ducted to obtain different model fits to available HIV and
STI epidemiological data. This was done to assess the
impact of parameter uncertainty upon the model impact
estimates. Latin Hypercube Sampling, a type of stratified
Monte Carlo sampling, was used to randomly generate
over 10,000 different parameter sets, from the given
parameter ranges (Table 1) [25]. In Latin Hypercube Sam-
pling, probability distribution functions are defined for
each parameter and the uncertainty intervals for each
parameter are split into N strips of equal probability,
where N is the number of runs undertaken in the uncer-
tainty analysis. For each run, an interval is randomly cho-
sen without replacement from each parameter uncertainty
range, and a parameter value is randomly chosen from
within the interval [25]. The actual number of parameter
sets sampled was chosen to give sufficient model fits that
generated HIV and STI prevalences within the 95 % CI of
the CSW HIV prevalence in 2003 and STI prevalence in
1999 and 2003. The uncertainty range of the results was
defined as the range within which 95% of the model fits
lie. A simple linear regression analysis was performed on
the different model fits to explore if there were any associ-
ations between the input parameters and different out-
puts (SPSS 12.0.1). To take into account the variability in
the uncertainty of different inputs, standardised regres-
sion coefficients were used to measure the strength of
association, and p-values were given by t-tests.
Costing methods
Cost collection was based on the Costing Guidelines for
HIV Prevention Strategies [26] and used an ingredients
based methodology. Total provider costs were collected
retrospectively. Financial and economic costs of the inter-
vention were estimated for the period between the two
surveys. Financial costs represent actual expenditure on
goods and services purchased whereas economic costs
reflect the opportunity cost of the project and also include
the market value of goods or services that were not fully
paid for, such as volunteer time and/or donated goods.
Costs were classified as recurrent (personnel, supplies,
transport, building maintenance) or capital (training,
start-up costs, buildings, vehicles) and by category of pro-
gramme input.
Input identification – Recurrent costs
Personnel records and staff interviews were used to iden-
tify staff and volunteers working on the project. Records of
peer educator and other volunteer numbers, expenditures
on medical and non-medical supplies as well as daily
transport, building operating and maintenance costs
(including communications) were obtained from project
monitoring documentation and accounts. Additional
transportation and communication expenses met by
project staff were identified from interviews with person-
nel. Other recurrent items include expenses for meetings,
workshops and special events (subsistence, accommoda-
tion etc), planning meeting costs, exposure visit costs,
bank fees and support to people living with HIV/AIDS.
Input identification – Capital costs
Although the project began before our evaluation period,
interviews with staff indicated that the 1999 baseline sur-
vey was key to recruiting CSWs and peer educators to the
project. For that reason, and in the absence of earlier start-
up data, the costs of the survey were estimated from
project accounts and included as a start-up cost for the
project. Staff training is a core activity of Jyoti Sangh. For
training activities based in Gujarat, costs were calculated
based on the number of participants, the number of days
attended and the estimated cost per person day for an
AMCACS training workshop. For other training activities,
costs were obtained from expenditure records and inter-
views with staff.
Buildings used by the project were identified through
interviews with staff and project records. Although the
project does not own any vehicles, it was found that many
staff use their own vehicles. Inventories were used to iden-
tify and estimate the prices paid for equipment used by
the project (medical, audio-visual and furnishings).
Input valuation – Financial costs
Financial costs were valued as actual expenditure by the
project on the identified recurrent and capital items over
the period of the analysis. Capital costs were annualised
using straight line depreciation assuming a project life of
10 years.
Input valuation – Economic costs
In obtaining the economic cost of personnel, full-time
staff were assumed to work 100% of their time on thePage 6 of 13
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tain their time spent on the project. The value of their time
was based on the wages they could command in the local
market. The value of volunteer time was estimated
through interviews with a sample of seven peer educators
and staff. The average time spent on the project by each
peer educator and their average monthly income was cal-
culated from these interviews, and was used to estimate
the annual economic cost of all peer educators. The effect
of the uncertainty in this calculation is explored using the
extreme values (minimum and maximum) obtained for
the peer educators' value.
Records did not identify the actual quantity of drugs or
other supplies used and there were no major donations of
these items, so for these inputs the economic cost was
considered equivalent to the financial cost. The economic
costs of transport, building maintenance and communica-
tion and other recurrent items were also valued using
project expenditure. In the case of transport and commu-
nication, additional costs, incurred by staff out of their
own pocket, were estimated from staff interviews and
included in the calculation. To minimise recall bias, these
costs were obtained for the most recent year of activity
through interviews and extrapolated to earlier years.
The value of training and start-up items were valued at
their financial cost. The 2004 rental value of the properties
was used to estimate the economic value of buildings.
Vehicles owned by staff have been included as economic
costs by valuing them at the replacement value of a Bajaj
scooter (the most common form of transport among staff)
and assuming that 25% of their usage is related to project
activities. The uncertainty around this value was explored
by assuming that 10% to 50% of their usage is related to
project activities. For the economic costs of other equip-
ment, where possible, a local market price was obtained
for the item. If this was not available the price paid was
used.
Capital costs were annualised using an expected length of
life ranging from 5–10 years, depending on the item, and
the standard discount rate of 3% [27]. The effect of vary-
ing the discount rate from 3–10% was explored.
All costs were converted to constant 2004 prices based on
the consumer price index [28] and summed to obtain an
annual cost.
Cost-effectiveness analysis
The cost-effectiveness ratio was defined as the change in
cost over the change in effectiveness relative to having no
intervention. In this case, the effectiveness was defined as
the number of HIV infections averted and so the cost-
effectiveness was the total costs divided by the total HIV
infections averted between the first and second epidemio-
logical surveys (51 months). The numbers of STIs averted
were not included in the effectiveness measure because of
the simplified nature in which the STIs were modelled. As
no future costs and outcomes were included, no further
discounting was carried out. Once the cost per HIV infec-
tion averted and been estimated, the cost per disability life
year (DALY) gained was calculated using methods
described in Fox-Rushby & Hanson (2001) [29]. The
assumptions used in these calculations are described in
Appendix 4 [see Additional file 4].
A two-way sensitivity analysis was carried out to test the
robustness of the cost-effectiveness estimates to assump-
tions regarding key parameters. We used the extreme val-
ues of cost and impact to establish a range for the cost-
effectiveness ratio.
This project was approved by the ethics committee of the
Ahmedabad Municipal Corporation AIDS Control Soci-
ety, Gujarat, India.
Results
There were 119 runs that fit the survey data of HIV preva-
lence amongst CSWs in 2003 and STI prevalence amongst
CSWs in 1999 and 2003. These model fits project that the
intervention averted 624 (Uncertainty range: 310–1,191)
HIV infections amongst CSWs in Ahmedabad from the
beginning of September 1999 to the end of November
2003 (51 months) – 53.8% (Uncertainty range: 38.4%–
68.8%) of the HIV infections that would have occurred
without the intervention. In contrast, 5,131 (Uncertainty
range: 2,282–8,896) HIV infections were averted among
clients – 51.2% (Uncertainty range: 33.4%–64.1%) of
those that would have occurred.
The model predicts that the intervention resulted in a
reduction in the STI prevalence amongst the clients and
commercial sex workers, which would have been stable
otherwise. Indeed, if there had been no intervention, the
HIV prevalence in December 2003 would have been
25.7% (Uncertainty range: 16.5%–39.4%) among CSWs
and 3.1% (Uncertainty range: 1.4%–5.7%) among clients,
nearly twice as high as the observed and projected HIV
prevalences amongst CSWs and clients in 2003 with the
intervention (1.6%, Uncertainty range: 0.9%–2.9% for
clients). The model estimates that the STI prevalence of
clients in the absence of intervention would have been
8.1% (Uncertainty range: 4.5%–12.2%), compared to
4.1% (Uncertainty range: 2.21%–4.35%) in the presence
of intervention. Without the intervention, the model
projects that the overall CSWs STI prevalence would have
remained stable at 75.5%.Page 7 of 13
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Table 3 shows the standardised regression coefficients for
the multi-linear regression analysis undertaken on the
input and output of the uncertainty analysis. The main
model parameters that had a significant impact upon the
different impact outcomes of the intervention programme
were the STD cofactor effect per sex act, proportion of
CSWs recently reached, HIV transmission probability per
sex act, average duration of STDs, and the average number
of CSWs seen by each client per month. It is noted that the
proportion of CSWs reached using STD services per
month is not significantly associated with any of the out-
puts. This is because few infected CSWs attended the clinic
each month (2.8%–4.1%) and so it had negligible effect.
Probably for the same reason, the average proportion of
STDs treated effectively cured is also not significantly asso-
ciated with any of the outputs.
Cost analysis
The total economic and financial cost of the intervention,
cost breakdown, and average annual costs are shown in
Table 4. The total financial cost for the period of evalua-
tion is USD 202,042 in 2004 currency. Economic costs are
2.7 times higher than the financial costs, reflecting the
importance of the volunteer time, peer educators time and
contributions from staff and peer educators in the form of
communications and transport to the project. Personnel
and peer educator costs are the most important project
cost, and so the total costs are highly sensitive to assump-
tions made about the value of peer educator time. The
average costs were relatively insensitive to variations in
the other uncertain variables – vehicle costs and the dis-
count rate.
Using the average monthly number of CSWs reached from
monthly records, the financial and economic cost per
CSW reached per month are USD 86 and USD 240,
respectively. The annual equivalents are USD 20 and USD
56, respectively.
Cost-effectiveness analysis
The results of the cost-effectiveness analysis of this inter-
vention programme are presented in Table 5 using 2004
currency. The cost-effectiveness ratio is presented with
and without the peer educator economic costs because of
the uncertainty around these estimates and to aid compa-
rability with other studies that do not include these costs.
The cost-effectiveness ratio ranges from USD 33.7–133.4
per HIV infection averted, when peer educator costs are
valued at the financial cost. When the peer educator costs
are included the ratio increases nearly two-fold, ranging
from USD 55.6–218.5 per HIV infection averted. The
costs per DALY saved range from USD 1.9 to 7.5 and USD
3.1 to 12.3, for the two scenarios, respectively.
Discussion
This study used mathematical modelling and economic
methods to evaluate the impact of the Jyoti Sangh HIV
prevention project for CSWs in Ahmedabad. The project
reached about three-quarters of the estimated CSW popu-
lation in the city by the end of 2003 and involved three
major components which have a direct impact on HIV
transmission: promotion and distribution of condoms;
free STD treatment; and counselling and behavioural
change through peer education. For the period from the
beginning of September 1999 to the end of November
2003 (51 months in total), the model projected that the
intervention averted about half of the HIV infections that
would have occurred amongst CSWs and clients in
Ahmedabad without the intervention. The total number
of HIV infections averted was estimated to be 5,755
(Uncertainty range: 2,548–10,140), and the cost-effective-
ness ratio ranged from USD 38 to USD 133 per HIV infec-
tion averted when peer educator costs were excluded.
When the peer educator costs were included the ratio
ranged from USD 56 to USD 219.
Based on mathematical modelling, it has been suggested
that sex worker interventions could drive the Indian HIV
epidemic "to extinction" [30]. By assuming the proportion
of unprotected sexual contacts reduces from 67% to 25%
through condom promotion among CSWs and their cli-
ents, Nagelkerke et al. [30] predicted a fivefold decrease in
the HIV prevalence in India after 30 years compared to if
no intervention had occurred. For comparison, STI man-
agement alone, when assumed to result in a 30% reduc-
tion in HIV transmission, made the HIV prevalence
decrease two- to threefold. Given these long-term impact
predictions, it is important that effective interventions
such as the Jyoti Sangh project are continued. Even
though the model predicts that this intervention resulted
in a 50% reduction in incident infections, there was still a
modest increase in HIV prevalence observed from 1999 to
2003. This emphasizes the importance of using modelling
to estimate the impact of HIV prevention projects and
highlights that more may need to be done to reduce HIV
incidence in this setting.
In a recent international initiative to evaluate the cost-
effectiveness of various strategies to combat HIV/AIDS in
developing countries, the cost per HIV infection averted of
peer education and treatment of STI for CSWs in World
Health Organisation South East Asia Region (Sear-D
region), of which India is a member, was found to be 45,
47 and 50 international dollars (year 2000) given a cover-
age level of 50%, 80% and 95% respectively [31]. Our cost
per HIV infection averted converts to the international
dollar equivalent of 290 (excluding peer educator eco-
nomic costs). The difference in these estimates can be
attributed to differences in methodology to both costingPage 8 of 13
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analysis.
Standardised 
regression coefficient
Outputs of the mathematical model (dependent variables)
Model input 
parameters 
(independent variables)
CSW HIV averted (%) CSW HIV Prevalence 
(%) Difference
Client HIV averted (%) Client HIV Prevalence 
(%) Difference
Overall number of 
CSW at any point in 
time
-0.002 0.023 0.000 0.041
Proportion of CSW 
recently reached by 
intervention
0.566† 0.219† 0.520† 0.174†
Proportion of CSW 
reached using STD 
services per month
0.005 -0.004 0.003 0.020
Average proportion of 
STDs treated 
effectively cured
0.015 -0.020 0.004 -0.015
Proportion of 
unreached CSW 
reporting using 
condoms
None of the time 0.415 0.215 0.259 0.092
Some of the time 0.245 0.096 0.107 0.036
All of the time 0.109 0.037 -0.029 -0.046
Proportion of reached 
CSW reporting using 
condoms
None of the time -0.280 0.233 -0.184 0.230
Some of the time -0.258 0.655 -0.032 0.618
All of the time -0.084 0.832 0.149 0.724
Initial HIV prevalence 
of CSWs
-0.272† 0.097 -0.220† 0.078
Average duration of 
STDs (months)
CSWs -0.049 -0.365† -0.139* -0.227**
Clients -0.344† -0.547† -0.426† -0.367†
Average duration of 
initial high infectivity 
phase (months)
0.129† 0.157† 0.154† 0.092*
Average time span 
(months)
CSWs sell sex -0.034 -0.003 -0.073** -0.013
Clients buy sex -0.068* 0.115** 0.036 0.122**
Average no. of clients 
per month per CSW
Unreached 0.211** 0.182 0.138* 0.112
Reached -0.242† -0.153 -0.145* -0.091
Average number of 
CSW seen by one client 
per month
0.012 0.442† 0.084 0.773†
Proportion of time 
condom used, 
corresponding to
"None of the time" -0.143† -0.181† -0.142† -0.175†
"Some of the time" -0.029 -0.069 0.024 -0.045
"All of the time" 0.392† 0.179† 0.275† 0.142**
HIV Transmission 
probability per sex act
Male to Female 0.353† 0.692† 0.482† 0.211**
Female to Male 0.197† 0.661† 0.302† 0.696†Page 9 of 13
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[31] will have produced much greater impact projections
because they compared their intervention impact against
the hypothetical 'no condom use' and 'no STI treatment'
scenario, and estimated the impact amongst the general
population. Also, it is unclear whether their cost estimates
include the value of peer educator time. Indeed, rarely are
these costs included in the costing of HIV prevention
projects which maybe due to the different motivations of
traditional volunteers who might forego earnings and
peer educators who may actually acquire additional bene-
fits from working in this manner. Together with the uncer-
tainty in these values identified in this study, this lack of
evidence calls for improved methods for understanding of
STD Transmission 
probability per sex act
Male to Female -0.129** -0.271† -0.180† -0.136*
Female to Male -0.172† -0.220† -0.200† -0.125*
STD cofactor effect per 
sex act
0.604† 1.119† 0.727† 0.790†
Multiplicative cofactor 
during high infectivity 
phase
0.107† 0.168† 0.132† 0.133**
Proportion of time 
condom used that 
provides protection
0.283† 0.140** 0.226† 0.124*
* ≤ 0.05 ** ≤ 0.01 † < 0.001 CSWs: Commercial sex workers STD: sexually transmitted disease
Table 3: Standardised regression coefficients of multi-linear regression model obtained from inputs and outputs of model uncertainty 
analysis. (Continued)
Table 4: Total costs, cost breakdown, and average costs in constant 2004 Indian Rupees (INR) and American Dollars (USD)
Cost Category Financial Economic~
INR USD % INR USD %
Capital
Start up 61,186.29 1,328.98 0.7% 55,599.14 1,207.63 0.2%
Training 273,409.70 5,938.53 2.9% 247,149.71 5,368.15 1.0%
Buildings8 569,947.10 12,379.39 6.1% 1,873,552.80 40,694.02 7.2%
Vehicles - - 0.0% 20,216.74 439.11 0.1%
Medical equipment 18,108.58 393.32 0.2% 16,451.42 357.33 0.1%
Non-medical 
equipment
6,293.75 136.70 0.1% 5,719.04 124.22 0.0%
Total Capital 
Costs
928,945.41 20,176.92 10.0% 2,218,688.86 48,190.46 8.6%
Recurrent
Personnel 3,442,371.55 74,769.15 37.0% 6,567,802.58 142,654.27 25.4%
Peer educators 1,309,599.26 28,444.81 14.1% 11,468,762.91 249,104.32 44.3%
Supplies – medical 168,979.54 3,670.28 1.8% 168,979.54 3,670.28 0.7%
Supplies – non 
medical
1,035,064.04 22,481.84 11.1% 1,035,064.04 22,481.84 4.0%
Transport 886,697.44 19,259.28 9.5% 2,214,647.44 48,102.68 8.6%
Building operating 
and maintenance
375,282.24 8,151.22 4.0% 1,066,256.73 23,159.36 4.1%
Other 1,155,068.08 25,088.36 12.4% 1,149,388.94 24,965.01 4.4%
Total Recurrent 
Costs
8,373,062.15 181,864.95 90.0% 23,670,902.19 514,137.75 91.4%
TOTAL COSTS 9,302,007.56 202,041.87 100.0% 25,889,591.04 562,328.22 100.0%
Average cost per CSW reached (assumes 2342 CSWs are reached*):
Over evaluation 
period
3,971.82 86.27 - 11,054.48 240.11 -
Annualised 934.55 20.30 - 2,601.05 56.50 -
CSWs: Commercial sex workers. ~ Financial and economic values for the capital items (except for buildings) were considered equal. However, 
costs were discounted in the economic valuation (3%) resulting in economic costs being lower than financial costs for these items. 8The economic 
value of buildings is based on local market survey. * estimated as in the impact model i.e. 0.78 of the estimated CSW population.Page 10 of 13
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the value of their time to increase our confidence in the
estimates and their impact on cost-effectiveness. How-
ever, the results compare favourably with interventions in
sub-Saharan Africa, where the cost per DALY save for CSW
peer education projects was estimated to be between 4.5
and 7.9 USD (2004 prices) [32]. In addition, the undis-
counted lifetime costs of AIDS illness in India is approxi-
mately USD 1200 [33]. Thus given the limited access to
HAART in India, if we assume no HAART, preventing the
number of infections as predicted in the model would
result in a cost saving of between USD 3.1 –12.1 million.
With HAART, the savings would be much greater.
There is a less difference between the results from Jyoti
Sangh and other studies using locally collected data. The
results from 32 other HIV intervention programmes
among CSWs in Tamil Nadu and Andhra Pradesh [34,35],
reveal costs per CSW reached ranging from 5 USD to 50
USD. Also from these studies it is apparent that the pro-
gramme in Ahmedabad had greater scale than most of its
counterparts in the two southern states, with only three
programmes in Andhra Pradesh reaching greater numbers
of CSWs (3,847, 4,690 and 6,379 respectively in fiscal
year 2002–2003) [35]. In contrast, the proportion of
CSWs using STD services per month (2.8%–4.1%) in
Ahmedabad was much lower than the number of CSWs/
clients referred for STI treatment per CSW reached in any
of the south Indian projects in one of the former studies
[34]. However, this difference could be because a low pro-
portion of those referred are using services. In addition, as
noted in the results, this proportion was not significantly
associated with the impact projections of the Jyoti Sangh
project. Indeed, it is likely that unless there is a significant
increase in the number of CSWs or clients attending the
Jyoti Sangh STI clinics, the clinics will have negligible
effect on HIV and STI transmission in Ahmedabad.
Despite this, the clinics are still likely to provide a benefi-
cial point of contact for CSWs and their clients.
Our mathematical model was limited to the sexual rela-
tionships between CSWs and their clients, and excluded
any HIV and STI transmission to other partners. No
attempt was made to estimate the impact of the interven-
tion programme upon the general population beyond the
clients, and so our impact projections are likely to under-
estimate the real impact of the project. In addition, the
model simulated the transmission of all the STIs together
and so did not separate cofactors for each STI. This may
have reduced the accuracy of our projections. Limitations
in data, especially amongst the clients, resulted in sub-
stantial uncertainty in our impact estimates. Improve-
ments in routine data collection and management, will
certainly improve the quality of future impact estima-
tions.
We did not incorporate the evolving nature of the inter-
vention programme into the model. In reality, the inter-
vention programme has been increasing in coverage, and
improving their service through feedback from peer edu-
cators and gaining experience through practice. This
increases the uncertainty in our estimates of coverage
parameters. However, the model uncertainty analysis and
fitting procedures minimized the effects of this uncer-
tainty on the model predictions.
There were some differences between the sampling meth-
ods used in the two surveys, and in the survey estimates
for the state of origin of the CSWs, and the proportions
living with a husband or alone (Table A2). They were not
adjusted in the model, and were a common limitation of
analyses that use data not collected for modelling pur-
poses.
Another limitation of the analysis was that HSV-2 trans-
mission was not modelled as discussed in the Methods.
This was due to a lack of applicable HSV-2 prevalence
data. However, it is unlikely that the intervention would
substantially affect the prevalence of HSV-2 over 33
Table 5: Cost-effectiveness analysis result (in constant year 2004 currency)
Peer educator cost valued as financial cost Peer educator input valued as economic cost
No. of HIV infections averted among CSWs and 
clients (95% UR)
5,755 (2,592–10,087)
Total cost (95% UR) (INR) 15,730,427 (15,653,389–15,918,536) 25,889,591 (25,812,552–26,077,699)
Cost per HIV infection averted (95% UR)
INR 2,732.87 (1,552–6,141) 4,498.63 (2,559–10,060)
USD 59.37 (33.7–133.4) 97.71 (55.6–218.5)
Cost per DALY saved (95% UR)
INR 153.95 (87–346) 253.38 (144–567)
USD 3.34 (1.9–7.5) 5.50 (3.1–12.3)
CSWs: commercial sex workers INR: Indian rupees UR: Uncertainty Range USD: US Dollars Note: The exchange rate: INR46.04 = USD1.00 
(average for the year 2004)
Source: [39]Page 11 of 13
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lation and the fact that it cannot be cured.
Recall bias in the two surveys is a limitation in this study,
as it is hard to determine to what extent the data collected
reflect reality except that the large drop in STI prevalence
concords with the reported decreases in risk behaviour.
Conclusion
This study demonstrated that targeted CSW interventions
in India can be cost-effective, and highlights the impor-
tance of replicating this effort in other similar settings.
This impact study can be used as a reference from which
to compare the impact of other intervention programmes
in India.
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